Cytokinetics, Incorporated (CYTK) Profit Margin
Cytokinetics, Incorporated (CYTK) gross and net profit margin history with trends. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2016-12-31 | 15.46% |
| 2017-12-31 | -955.94% |
| 2018-12-31 | -337.41% |
| 2019-12-31 | -452.93% |
| 2020-12-31 | -228.00% |
| 2021-12-31 | -305.72% |
| 2022-12-31 | -411.21% |
| 2023-12-31 | -6988.63% |
| 2024-12-31 | -3191.11% |
| 2025-12-31 | -891.60% |
How CYTK compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| VSTM | Verastem Inc. | -677.59% |
| AGIO | Agios Pharmaceuticals Inc. | -764.01% |
| XBIT | XBiotech Inc. | -820.45% |
| ACRS | Aclaris Therapeutics Inc. | -829.58% |
| DMAC | DiaMedica Therapeutics Inc. | -1146.80% |
These are five companies in the same sector as CYTK with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Cytokinetics, Incorporated Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("CYTK", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | CYTK | $75.64 | -1.06% | 2.11M |
| 3 | ||||
| 4 | ||||
| 5 |